Clinical trial
Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without…
NCT00189371 · AGO Study Group, Other · Terminated
Key facts
| NCT number | NCT00189371 |
|---|---|
| Title | Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum |
| Official title | Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum |
| Lead sponsor | AGO Study Group, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum, Platinum Sensitve Relapse, Anemia |
| Intervention type | Drug |
| Interventions | paclitaxel, carboplatin, epoetin alpha |
| Enrollment | 300 |
| Start date | Feb 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | Sep 19, 2005 |
| Last update posted | Sep 19, 2005 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: